Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
The co-existence of high prevalence of vitamin D inadequacy among Canadians and high prevalence of systematic autoimmune rheumatic diseases (SARDs) raise the question on relationship between the two situations. 
No comment yet.
Sign up to comment
Scoop.it!
The limited availability of pediatric rheumatologists for teaching in pediatric residency programs negatively impacts resident education about rheumatology. At present, there are no educational websites available for trainees ...
Scoop.it!
Fundamentals of Rheumatology Course was created to meet the specific needs of those transitioning into rheumatology practice such as nurses, office nurses, licensed practical nurses (LPN), medical assistants (MA) and office managers, staff or other clinicians that could benefit from one easy-to-access online resource that offers a current evidence-based comprehensive overview of the rheumatologic disorders and insurance preauthorization.
A course at American College of Rheumatology: http://www.rheumatology.org/index.asp
See also, The Rheumatology Research Foundation: http://www.rheumatology.org/foundation/about.asp#src=social
Via Alfredo Corell
Scoop.it!
A blockbuster drug made by Amgen is no more effective than a cocktail of cheaper generic therapies in treating a severe joint disease affecting an estimated 1.3 million Americans, according to a new study funded by the Department of Veterans Affairs. Via Richard Meyer
Richard Meyer's curator insight,
June 12, 2013 7:13 AM
The findings could prompt changes in the way physicians treat patients, potentially saving significant amounts of money, although some researchers suggested that current treatments may be too well entrenched to be dislodged. Amgen's Enbrel, which had global sales of $4.23 billion last year, and similar biologic drugs are often prescribed to treat rheumatoid arthritis after patients have failed to respond to a generic drug called methotrexate, which is the most commonly used front-line therapy.
Scoop.it!
(Reuters) - Roche Holding AG said U.S.regulators have widened the approved use of rheumatoid arthritis drug Actemra to include patients typically in earlier stages of treatment for the joint disease.Actemra... Via Richard Meyer
Scoop.it!
I have just returned from the annual European Rheumatology EULAR 2013 meeting in Madrid. This massive conference was attended by about 14,000 delegates, with over 500 'posters' per day and over 230... Via Marie Ennis-O'Connor
Scoop.it!
|
Scoop.it!
FDA approves infusible golimumab for treatment of RA patients
Scoop.it!
(Credit: KayVee.INC/Flickr). JOHNS HOPKINS (US) — Osteoarthritis, a painful disease thought to be primarily a problem with the cartilage that cushions joints, may actually be caused in large part by the bone underneath.
Scoop.it!
'US News & World Report' ranks Johns Hopkins best hospital for rheumatology
Scoop.it!
Wayne Channon's curator insight,
July 14, 2013 9:17 AM
Umbilical cord blood stem cells could be the future of regenerative medicine.
Scoop.it!
From BioPortfolio: Encouraging data from preclinical studies, and ongoing clinical trials, suggest that mesenchymal stem cells (MSCs) might provide the disease-modifying therapy t...
Scoop.it!
Original Article from The New England Journal of Medicine — Surgery versus Physical Therapy for a Meniscal Tear and Osteoarthritis Via sportEX
|
